Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Bristol-Myers Squibb patents new lysophospholipid receptor antagonists

Nov. 8, 2012

Bayer presents new protein kinase Akt inhibitors for cancer

Nov. 8, 2012

Spanish group synthesizes new histone deacetylase inhibitors

Nov. 7, 2012

New JNK1 inhibitors revealed by Roche

Nov. 7, 2012

New beta-secretase inhibitors presented by Roche and Siena Biotech

Nov. 7, 2012

Karo Bio designs novel estrogen receptor-beta ligands

Nov. 7, 2012

GlaxoSmithKline divulges new mTOR inhibitors

Nov. 7, 2012

Novel ACAT inhibitors disclosed by Pierre Fabre Medicament

Nov. 7, 2012

Siena Biotech presents new Wnt signaling inhibitors

Nov. 6, 2012

Bayer Schering Pharma synthesizes new protein kinase inhibitors

Nov. 6, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...